Complementary and alternative medicines (CAM) are used widely for treating atopic eczema (AE), commonly in conjunction with conventional medicines prescribed by mainstream healthcare professionals (HCPs). This cross-sectional survey evaluated the knowledge, general attitudes and practices regarding CAM among dermatologists, paediatricians, general practitioners (GPs) and pharmacists treating patients with AE in Durban, KwaZulu-Natal. Methods: Questionnaires were sent via email or hand-delivered to HCPs nearby. Results: Of the 330 respondents, 220 (67%) were males and 110 (33%) females. Most (40%) were > 50 years. GPs and pharmacists were significantly more embracing of CAM compared with dermatologists and paediatricians. The majority were not familiar with most CAMs for AE. More GPs (29%) and pharmacists (43%) recommend CAM compared with dermatologists (8%) and paediatricians (5%). GPs and pharmacists were also amenable to referring patients to CAM practitioners. The majority do not initiate discussions with their patients regarding CAM use nor enquire when taking a history. Many dermatologists (65%) and pharmacists (51%) reported that their patients ask about CAM. All dermatologists, 95% of paediatricians, 87% of GPs and 55% of pharmacists reported having no training in CAM but believed it should be included in their curriculum. Most are interested in learning about CAM and agreed that it would better prepare them in managing patients. Conclusion: This study demonstrated poor CAM knowledge and communication between HCPs and patients but a strong interest amongst HCPs to learn more. There is an urgent need for continuing education programmes and inclusion in undergraduate curriculums, which will assist HCPs in influencing better patient outcomes.
Background
Atopic eczema (AE) is one of the most common skin diseases affecting patients who present to dermatological practices in South Africa (SA). 1 Over the last decade, the lifetime prevalence of physician-diagnosed AE has almost doubled in SA. 2 This rise continues despite accessible effective treatments. 3 Due to AE's chronic, relapsing nature and the unattainability of complete clinical cure, patients are continually exploring complementary and alternative medicines (CAM) in search of a cure. 3 CAM's popularity in the management of AE is well established. 4 Non-compliance with therapy is a major contributor to AE's persistence. Reported non-compliance rates are 30-60% with most regimes. 5 Common reasons cited for non-compliance were apprehension of the danger of steroids, concern about side effects of other prescribed medication and a preference for 'natural' therapy. 5 This presents a dilemma for practitioners for many reasons: unproven effectiveness of many CAM, less funding for medication with proven reliability, difficulty in evaluating treatment and perpetuation of 'natural' therapists' perspectives that steroids are dangerous, resulting in long-term suffering. 5 Although evident from the literature that patients have embraced CAM, 3 healthcare professionals (HCP) may not be as embracing. Their attitude and knowledge of CAMs will influence their proactiveness in enquiring about CAM and confidently discussing proven/unproven remedies with their patients, thereby influencing an overall positive clinical experience and disease course.
Several international studies have explored the knowledge, attitudes and practices amongst general practitioners (GPs), physicians, pharmacists, paediatricians, academic doctors and other healthcare workers towards CAM. [6] [7] [8] [9] [10] [11] These studies focused on general CAM use and none within the context of a specific disease. We found no published studies conducted in SA or elsewhere investigating HCPs' knowledge, attitudes and norms of practice with regard to CAMs for AE. Given the extensive use among South African patients with AE, 12 the views and rationales among South African HCPs treating patients with AE requires investigation.
Objectives
We conducted a cross-sectional survey among mainstream HCPs treating patients with AE in Durban, KwaZulu-Natal, with the aim of exploring their knowledge, awareness of use, recommendations, practices and attitudes to CAM use amongst their AE patients.
Methods
The Ethics Committee of University of KwaZulu-Natal provided approval (BE219/14).
Study population
Practising dermatologists, paediatricians, GPs and pharmacists in Durban were selected randomly using professional societies' databases and the telephone directory. HCPs had to be practising in a private practice where they treat AE patients; however, dermatologists and paediatricians were also considered if they consult in the public sector. Sample sizes were calculated based on population estimates of each group of HCPs represented in this study in Durban and surrounding areas (within 20 km).
Participants were recruited between October 2014 and February 2015. A total of 330 HCPs responded to the survey: 25/34 dermatologists (74% response rate); 41/61 paediatricians (67% response rate); 182/570 general practitioners (33% response rate); 82/158 retail pharmacists (52% response rate).
Data collection
Participants were sent an email with a link to the questionnaire. Questionnaires were also hand-delivered to HCPs practising nearby. Three reminders were sent electronically and via telephone calls.
The questionnaire covered the following sections:
• practitioner and practice particulars;
• general and demographic particulars of the HCP;
• views on/attitudes to CAM for eczema;
• knowledge of CAM for eczema;
• professional practices with regard to CAM;
• education regarding CAM for eczema.
Statistical analyses
Data was analysed using Stata 13.0® (StataCorp LP, College Station, TX, USA). Categorical data were summarised using frequencies and percentages. Association between type of HCP and attitudes, familiarity and practice using CAM variables were assessed using the Pearson chi-square test and Fisher's exact test if any cell count contained fewer than five expected observations. We considered a p-value < 0.05 as being statistically significant.
Results

Demographics
The 330 HCPs respondents comprised 26 dermatologists, 40 paediatricians, 182 GPs and 82 pharmacists. There were 220 (67%) males and 110 (33%) females; 113 (34%) were Muslim practitioners, 104 (32%) Hindu, 99 (30%) Christian and 1 (0.3%) Buddhist. Two were atheist (0.6%), 1 agnostic (0.3%) and 10 did not respond (3%). The majority (132) were > 50 years (40%), 105 (32%) were 31-40 years, 76 (23%) were 41-50 years and 17 (5%) were < 30 years. The majority were Indian practitioners (71%), 48 (15%) White, 42 (13%) Black and 7 (2%) Coloured.
Our study demonstrated that there was no statistically significant demographic factor, e.g. age, gender, religion or ethnicity, that was a predictor of HCPs' knowledge, attitudes and practices towards CAM. General practitioners (n = 182) 87% 2% 11%
Pharmacists (n = 82) 87% 1% 12%
(Continued)
HCPs' views/attitude towards CAM
Views/attitudes were assessed by the degree of agreement with general statements regarding CAM. Fewer specialists (8% dermatologists and 13% paediatricians) felt that CAM provides a more holistic healthcare approach compared with GPs (32%) and pharmacists (29%) (p = 0.002). Again, fewer specialists (8% dermatologists and 18% paediatricians) felt that CAM can offer benefits over conventional medicines compared with GPs (36%) and pharmacists (35%) (p = 0.001). Regarding the perception that the results from CAM are due to a placebo effect, more specialists (45% paediatricians and 27% dermatologists) than GPs (16%) and pharmacists (11%) were of this opinion (p < 0.001). More GPs (52%) and pharmacists (59%) felt that if physicians were more knowledgeable about CAM practices, their patients would have better clinical outcomes (p < 0.001). None of the dermatologists and only 3% of paediatricians felt that CAM produced a more complete clinical cure than conventional medicines. This was significantly less than the views of GPs (14%) and pharmacists (16%) (p = 0.037). More dermatologists (35%) and paediatricians (30%) felt that CAM interferes with standard medical care compared with GPs and pharmacists (both 15%) (p < 0.001).
These results are represented in Table 1 .
HCPs' familiarity regarding CAM
The percentage of HCPs that reported being very familiar with any of the CAMs frequently used for AE were low. Most were slightly familiar with probiotics and dietary supplements. However, it was evident that all HCPs were unfamiliar with the majority of the CAMs listed in Table 2 , with higher levels of unfamiliarity regarding Chinese herbal medicines (CHM) and homeopathy. GPs and pharmacists were more familiar with oral and topical herbal products than dermatologists and paediatricians.
HCPs' familiarity is shown in Table 2 .
HCPs' professional practices regarding CAM
The majority of HCPs never/rarely initiate discussions regarding CAM for AE (p = 0.006) and only sometimes have discussions with patients when a patient requests a CAM (no difference across HCP groups was noted) (p = 0.698). Although most reported not being confident in discussing CAM therapies with their patients, the majority reported that they always believe that HCPs treating patients for AE should regularly ask about CAM use. In general, most HCPs were unhappy to refer patients to CAM practitioners. More specialists (54% of dermatologists General practitioners (n = 182) 14% 55% 31%
Pharmacists (n = 82) 16% 50% 34%
11. CAM means quackery and makes fraudulent claims (p = 0.002)
General practitioners (n = 182) 6% 58% 36%
Pharmacists (n = 82) 10% 51% 39%
12. Interferes with standard medical care (p < 0.001)
Paediatricians (n = 40) 30% 13% 58%
General practitioners (n = 182) 15% 48% 37%
Pharmacists (n = 82) 15% 49% 37% 
Patients requesting CAM
More than half of the dermatologists (65%) and pharmacists (51%) reported that their patients ask questions about or request CAMs for AE. Fewer paediatricians (33%) and GPs (36%) reported this (p = 0.005).
HCPs' knowledge/education regarding CAM
All dermatologists and most paediatricians (95%) and GPs (85%) had no training in CAM compared with 55% of pharmacists (p < 0.001). A larger number of specialists did not access medical journals (p < 0.001), the internet (p = 0.005) or have discussions with other colleagues regarding CAM (p = 0.037) compared with GPs and pharmacists. Comparatively, pharmacists were among the HCPs who sourced CAM information most often. The majority of paediatricians (85%), GPs (83%) and pharmacists (82%) reported that CAM is never discussed at meetings whereas more than half of the dermatologists reported CAM being discussed in congresses (p < 0.001). Table 4 reflects these results.
HCPs' perspectives on CAM education
On assessing the HCPs' perspectives on CAM education, the majority responded positively to universities including CAM as part of the curriculum (p = 0.001). Most agreed that learning about CAM would better prepare them for treating patients with AE (p = 0.004) and the majority were interested in learning more about CAM for AE (p = 0.004). These results are shown in Figure 2 .
Discussion
Attitudes
The widespread use of CAM for AE among patients worldwide has been documented. 13 Data have also revealed extensive use among South African AE patients. 12 We thus explored the knowledge, attitudes and practices of South African HCPs in respect of CAM for AE.
The attitudes among HCPs in our study varied. Those with specialist training (dermatologists and paediatricians) were more sceptical, uncertain about the value and less receptive towards CAM compared with GPs and pharmacists who were significantly more positive and embracing of CAM. and 45% of paediatricians) reported never being happy to refer patients to CAM practitioners compared with GPs (25%) and pharmacists (22%).
HCPs' professional practice habits are shown in Table 3 .
HCPs' recommendation of CAM
Most South African HCPs do not recommend CAM for AE. However, in comparison, the majority of specialists (92% dermatologists and 95% paediatricians) do not recommend CAM compared with GPs (71%) and pharmacists (57%) (p < 0.001). This reflects a substantial number of GPs and pharmacists that do recommend CAM. Figure 1 represents these results. This positive attitude was seen in several other studies. A Texasbased study reported that a large number of GPs were positive about incorporating CAM into general practice (75%), referring patients to CAM practitioners (> 60%) and offering proven CAM therapies to patients (70%). 10 Saudi Arabian primary healthcare physicians also showed a positive attitude and 76% believed that CAM would lead to a better patient outcome.
14 GPs in a Qatar survey reflected support of CAM with 83% agreeing that it is a useful supplement to conventional medicine and included ideas and methods beneficial to the primary care physician. 6 The overall attitudes of Australian GPs and pharmacists towards CAM are positive. 15 In a South African-based study among pharmacists, almost half (47%) believed in the benefits of both conventional and herbal medicines and 64% perceived herbs to be therapeutically effective drugs. 16 Our survey shows a similar positive attitude among GPs and pharmacists.
Conversely, certain studies have demonstrated scepticism and uncertainty about CAM's value. The majority of academic doctors with dual academic and clinical roles in a Bristol, UK study expressed doubt due to the lack of scientific evidence. 9 This scepticism is seen amongst South African specialists (dermatologists and paediatricians) in our survey with many also having dual academic and clinical roles. The Texas-based study among GPs reported that in comparison with another study using the same instrument, a more positive attitude was seen among primary care practitioners compared with nonprimary care peers (sub-speciality physicians) at the Mayo Clinic. 10 GPs are generally based within the community and are exposed to a variety of diseases for which patients are using CAM. This type of family medical practice seems a more open forum for patients and doctors to discuss CAM choices, thus realising a more open approach from GPs. A study among paediatricians in the Netherlands, however, found a positive attitude towards CAM, mostly towards probiotics and dietary supplements whose action can be rationalised with those of conventional medicines.
Familiarity
The scepticism among HCPs can be attributed to their lack of knowledge. On assessing knowledge/familiarity, it was evident that the majority were unfamiliar with most CAMs for AE. GPs and pharmacists were more familiar with herbal products (oral and topical) compared with specialists. Higher levels of unfamiliarity were seen with CHM and homeopathy, possibly because the theory behind their action differs vastly from conventional medicine, as well as the limited exposure to CHM practitioners in Durban. Another Durban-based study amongst healthcare workers in HIV/AIDS clinics reflected poor CAM knowledge including homeopathy and CHM. 11 Likewise, 81% of Turkish dermatologists reported very little/no knowledge of CAM and more than half of paediatricians surveyed in the Netherlands also had little knowledge of CAM therapies. 17 Studies among GPs in Qatar and Saudi Arabia reported similar poor CAM knowledge (39% and > 63% respectively). 6, 14 However, several Australian surveys indicate that GPs are familiar with a wide range of CAM therapies. 15 Australian pharmacists reported that while a lack of knowledge about safety was a definite barrier to their recommendation, they still often recommended CAM alongside conventional medicines as part of the pharmacy protocol. 
Recommendations and referrals
Although most HCPs do not recommend CAM to their patients, more GPs (29%) and pharmacists (43%) do so compared with dermatologists (8%) and paediatricians (5%). Similarly, more GPs General practitioners (n = 182) 83% 15% 2%
Pharmacists (n = 82) 82% 15% 4%
Education
Our survey revealed that most South African HCPs acknowledge their lack of knowledge on CAM and want to be better informed. This lack of knowledge is due to lack of training in CAM in both the undergraduate and continuing education programmes. All dermatologists, 95% of paediatricians and 87% of GPs reported having no training in CAM. Pharmacists, on the other hand, have had a little more CAM training (45%). The majority of respondents believed that universities should include CAM as part of their curriculum. A similar number also agreed that learning about CAM would better prepare them for managing patients and are interested in learning more. These views correlate with other studies which have recommended that CAM be included in undergraduate medical and pharmacy curricula. 7, 16 Among Saudi Arabian primary healthcare physicians, 85% agreed that they should have knowledge of CAM.
14 In Qatar, almost all GPs (98%) were interested to learn more about CAM and most dermatologists in a study in Turkey also claimed that they would like to be better informed about CAM. 17 In a survey amongst paediatricians in Michigan, USA, 54% were keen on continuing medical education courses for CAM. 18 Academic doctors in Bristol, UK acknowledged that better doctor-patient communication and patient disclosure is required; however, their views on educating themselves on CAM were varied. 9 Our survey was comparable to most as the majority of HCPs (> 72% specialists, > 90% GPs and pharmacists) said that they wanted to learn more about CAM for AE.
Limitations
Although this study has been compared with those in other countries, our study was reflective of CAM practices specifically for AE whereas those of other countries were on general use of CAM. It is presumed that the attitudes, knowledge and practices of CAM for AE would be similar to CAM use in other contexts. The responses in the study may not represent the views of all South African HCPs as our study sample were majority Indian HCPs within the Durban metropolitan area.
Conclusion
It is clear that CAM is an established therapy for a large part of the population and, considering that CAM and conventional medicine are often used together, there is a potential for confusion in attribution of therapeutic benefits, adverse effects and drug interactions. Their concomitant use also creates a potential for non-compliance with prescribed therapy affecting overall clinical outcome. It is imperative that HCPs initiate discussions as well as realise and accept a responsibility in understanding their evidence-based role. HCPs need to become more conversant with common CAM therapies in order to influence better patient management and possibly better outcomes. Our study demonstrated poor CAM knowledge and communication between HCP and patient but a strong interest amongst HCPs to learn more. and pharmacists were amenable to referring patients compared with the specialists (Table 3) . Both practices are reflective of their general attitudes towards CAM. The concern is that those recommending CAM are doing so without adequate knowledge/ training. This lack of knowledge/training was reported among the majority of respondents in our study but did vary depending on CAM type. Recommendations despite knowledge were seen among Turkish dermatologists where 80% reported little/no knowledge, yet more than half have at some stage recommended topical herbal therapies and a significant proportion other herbal therapies. 17 With regard to referrals, 50% of paediatricians in a Michigan, USA study said that they would refer patients to CAM practitioners whereas only 27% of paediatricians in the Netherlands occasionally refer patients. 18 In a survey among Durban pharmacists, only 8% considered themselves sufficiently equipped to advise patients, yet 45% indicated that they did counsel patients on herbal medicines and these were recommended by 36% of respondents. In a Texas-based study, almost half (42%) of the primary HCPs did refer patients to CAM practitioners and 64% would like to. 10 Referral rates were low among Qatar GPs where 39% stated that they had poor CAM knowledge. 6 A greater number of doctors in Australia (68%) were in favour of referring patients to complementary therapists and most were familiar with various CAM therapies.
15
Communication
Although fewer HCPs in our survey recommend or refer patients to CAM practitioners, a fair number are doing so. Fewer paediatricians (33%) and GPs (36%) said that their patients ask about CAM compared with a larger number of dermatologists (65%) and pharmacists (51%). It appears that patients frequently ask for CAM for skin diseases. On assessing HCPs' practices when treating patients, our study indicated that the majority of South African HCPs do not initiate discussions with their patients regarding their CAM use. Even when a patient requests/asks about CAM it is not their practice always to discuss this with patients. Most do not even enquire about the patient's CAM use when taking a medical history. The majority reported a lack of confidence in discussing CAM therapies. This is undoubtedly due to their lack of knowledge as confirmed through this study.
Despite these practices, most believed that HCPs treating patients for AE should regularly ask patients if they are using CAM and most agreed that it is necessary for practitioners to have knowledge of the most prominent CAM treatments. As pharmacies are the major stockists of CAM products, patients expect pharmacists to have sufficient knowledge to advise them. This is an important aspect of a pharmacist's service. This reluctance is discussing CAM issues with patients is also seen in other studies. In the Netherlands, the majority of paediatricians seldom discuss CAM use with parents and among paediatricians in Michigan, USA, discussions regarding CAM were found to be mostly initiated by parents (85%). 18, 19 Even primary healthcare physicians in Saudi Arabia who claimed to be comfortable in counselling patients on certain types of CAM commonly used in their region were reluctant to initiate discussions regarding their patients' CAM practices. 14 Among GPs in Texas, USA, 84% stated that their patients initiated discussions around CAM. 10 On the other hand, a national Australian survey indicated that a large number of GPs who practice integrative medicine (66%) as well as almost half (47%) of those not practising integrative medicine do initiate CAM discussions with patients and a similar number also ask about its use when taking a history. 20 
